Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Yamamoto, T., Nakamura, J., Takabatake, Y
She has had decreased solid food intake, but has been drinking fluids and has good urine output
Current clinical or preclinical data suggest that long-acting amylin analogues have the potential to achieve weight loss equivalent to that of GLP-1 receptor agonists but with better tolerability, providing a better experience for patients and achieving high-quality weight loss by preserving lean muscle mass
After intravenous injection, the bovine serum albumin (BSA) and PENs-induced AD groups expressed typical clinical symptoms of anaphylaxis, for example wheezing, convulsion, unsteady gait, cyanosis and death, whereas the control, carrier protein and drug groups had no active systemic anaphylaxis symptoms
2 The researchers arrived at these conclusions after analyzing data from the U.S